Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2026-02-23 @ 8:56 PM
Study NCT ID:
NCT02604433
Status:
COMPLETED
Last Update Posted:
2023-04-18
First Post:
2015-10-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-02
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-05
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-21
First Submit QC Date:
None
Study First Post Date:
2015-11-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-12-06
Results First Submit QC Date:
None
Results First Post Date:
2020-01-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-05-25
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-03-23
Last Update Post Date:
2023-04-18
Last Update Post Date Type:
ACTUAL